SEATTLE (AP) _ Omeros Corporation (OMER) on Thursday reported a loss of $24.3 million in its first quarter.
The Seattle-based company said it had a loss of 50 cents per share. Losses, adjusted for non-recurring costs, came to 38 cents per share.
The drug developer posted revenue of $21.8 million in the period.
Omeros shares have climbed 67% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $18.55, an increase of 10% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER